Clients in the Media

November 12, 2025 | MeiraGTx
InnovationRx: Senate Punts On Health Insurance Subsidies To End Shutdown
Forbes (InnovationRx)
November 10, 2025 | MeiraGTx
In string of deals, Lilly nabs ultra rare eye disease gene therapy and RNAi partner
Endpoints
November 10, 2025 | MeiraGTx
Lilly’s pair of deals includes rights to MeiraGTx’s vision-restoring gene therapy: Deals Report
BioCentury
November 10, 2025 | MeiraGTx
Eli Lilly signs deal for MeiraGTx’s gene therapy for severe eye disease
Reuters
October 11, 2025 | MeiraGTx
MeiraGTx Gene Therapy Catches Lilly’s Eye In $475m Pact
Scrip
October 10, 2025 | MeiraGTx
Lilly bags eye-catching retinal disease gene therapy from MeiraGTx in $475M deal,”
FierceBiotech
May 17, 2025 | MeiraGTx
The New Era of Life Sciences: The Future is Now
Investment Reports (Newsweek)
April 16, 2025 | CAMP4 Therapeutics
Restoring healthy gene expression with programmable therapeutics
MIT News
March 14, 2025 | MeiraGTx
Plaudits For MeiraGTx And Its Parkinson’s AI Pact
Scrip
March 13, 2025 | MeiraGTx
MeiraGTx teams with cryptic AI startup, co-founded by Eric Schmidt, to advance Parkinson’s gene therapy
Endpoints